Beta Bionics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
11 Hughes, Irvine, California, 92618, Un...Phone Number
(855) 745-3800Website
www.betabionics.comRevenue
$119 MillionStock Symbol
BBNXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Beta Bionics
Beta Bionics® is a clinical stage medical technology company focused on the design, development, and commercialization of its iLet® Bionic Pancreas System. The iLet Bionic Pancreas is designed to use adaptive, self-learning, control algorithms, together with continuous glucose monitoring and pump technology, to autonomously compute and administer doses of insulin and/or glucagon and mimic the body's natural ability to maintain tight glycemic control. Beta Bionics is a for-profit, public benefit corporation and Certified B Corporation. Since its founding in 2015, its mission has been to help improve health outcomes and the quality of life of children and adults living with diabetes and other conditions of glycemic dysregulation. Beta Bionics operates in Massachusetts and California.Explore more
Beta Bionics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Beta Bionics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Beta Bionics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Beta Bionics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Beta Bionics has new funding data
Product Launch: Get notified when Beta Bionics launches new products
Check if Beta Bionics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Beta Bionics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Beta Bionics
Beta Bionics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Beta Bionics
Find 3 more new buyers
Compare Similar Companies to Beta Bionics
Compare insights from companies similar to Beta Bionics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Beta Bionics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Beta Bionics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Beta Bionics.
Beta Bionics financials insights
Gather financial insights about Beta Bionics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Angel/Seed
$1M
2017
Private Equity
$2.5M
2019
Series B
$63M
2022
Series C
$57M
2023
Series D
$100M
2024
Series E
$60M
2025
Stock Offering
$212.1M
Beta Bionics Tech Stack
A closer look at the technologies used by Beta Bionics
See more technologies
Most Recent Scoops
Hiring Plans
Beta Bionics has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Areas of expertise include: Defect Tracking, RESTful API, Technical Issues, Java (Programming Language), Medical Device Manufacturing, Product Testing, and Web Services Interoperability.
Hiring Plans
Open Position
Person-Based
Earnings, Finance
Person-Based
Pharmaceuticals, Customer Retention & Development
Project
Medical Research, Pharmaceuticals, Clinical Operations
Beta Bionics News & Media
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead ClaATTENTION NASDAQ: BBNX INVESTORS: Contact Berger Montague About a Beta Bionics, Inc. Class Action Lawsuit
PHILADELPHIA, Sept. 15, 2026 /PRNewswire/ -- Berger Montague PC, a leading national plaintiffs' law firm, announces a class action lawsuit against Beta Bionics, Inc. (NASDAQ: BBNX) ("Beta Bionics" or the "Company") on behalf of investors who purchased or acquired Beta Bionics securities...BBNX INVESTOR DEADLINE: Beta Bionics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
SAN FRANCISCO, Sept. 15, 2026 /PRNewswire/ -- Beta Bionics, Inc. (NASDAQ: BBNX) faces a securities class action, which seeks to represent investors who purchased or otherwise acquired shares of the company's common stock between July 30, 2025 and February 24, 2026. The lawsuit follows a...BBNX Court Alert: Beta Bionics Securities Fraud Class Action Deadline is Approaching on November 3 for Investors that Suffered Losses
A securities fraud class action lawsuit has been filed on behalf of Beta Bionics investors after its stock plummeted over 37% because Beta Bionics allegedly misled investors about the safety, efficacy, and commercial success of its iLet medical device, potentially violating the federal...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Beta Bionics
Sign Up For FreeTo access detailed company insights
Beta Bionics® is a clinical stage medical technology company focused on the design, development, and commercialization of its iLet® Bionic Pancreas System. The iLet Bionic Pancreas is designed to use adaptive, self-learning, control algorithms, together with continuous glucose monitoring and pump technology, to autonomously compute and administer d... Read More
